Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.
Identifieur interne : 006059 ( Ncbi/Merge ); précédent : 006058; suivant : 006060Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.
Auteurs : Gandhirajan Anugraha [Inde] ; Parasurama Jawaharlal Jeyaprita ; Jayaprakasam Madhumathi ; Tamilvanan Sheeba ; Perumal KalirajSource :
- Acta parasitologica [ 1896-1851 ] ; 2013.
Descripteurs français
- KwdFr :
- Agranulocytes (immunologie), Animaux, Anticorps antihelminthe (sang), Antigènes d'helminthe (administration et posologie), Antigènes d'helminthe (génétique), Antigènes d'helminthe (immunologie), Brugia malayi (enzymologie), Brugia malayi (génétique), Brugia malayi (immunologie), Filariose lymphatique (), Filariose lymphatique (immunologie), Immunoglobuline G (sang), Interféron gamma (sécrétion), Interleukine-4 (sécrétion), Interleukine-5 (sécrétion), Mâle, Prolifération cellulaire, Protéines d'helminthes (administration et posologie), Protéines d'helminthes (génétique), Protéines de fusion recombinantes (génétique), Protéines de fusion recombinantes (immunologie), Souris, Souris de lignée BALB C, Thiorédoxines (génétique), Thiorédoxines (immunologie), Vaccins synthétiques (administration et posologie), Vaccins synthétiques (génétique), Vaccins synthétiques (immunologie).
- MESH :
- administration et posologie : Antigènes d'helminthe, Protéines d'helminthes, Vaccins synthétiques.
- enzymologie : Brugia malayi.
- génétique : Antigènes d'helminthe, Brugia malayi, Protéines d'helminthes, Protéines de fusion recombinantes, Thiorédoxines, Vaccins synthétiques.
- immunologie : Agranulocytes, Antigènes d'helminthe, Brugia malayi, Filariose lymphatique, Protéines de fusion recombinantes, Thiorédoxines, Vaccins synthétiques.
- sang : Anticorps antihelminthe, Immunoglobuline G.
- sécrétion : Interféron gamma, Interleukine-4, Interleukine-5.
- Animaux, Filariose lymphatique, Mâle, Prolifération cellulaire, Souris, Souris de lignée BALB C.
English descriptors
- KwdEn :
- Animals, Antibodies, Helminth (blood), Antigens, Helminth (administration & dosage), Antigens, Helminth (genetics), Antigens, Helminth (immunology), Brugia malayi (enzymology), Brugia malayi (genetics), Brugia malayi (immunology), Cell Proliferation, Elephantiasis, Filarial (immunology), Elephantiasis, Filarial (prevention & control), Helminth Proteins (administration & dosage), Helminth Proteins (genetics), Immunoglobulin G (blood), Interferon-gamma (secretion), Interleukin-4 (secretion), Interleukin-5 (secretion), Leukocytes, Mononuclear (immunology), Male, Mice, Mice, Inbred BALB C, Recombinant Fusion Proteins (genetics), Recombinant Fusion Proteins (immunology), Thioredoxins (genetics), Thioredoxins (immunology), Vaccines, Synthetic (administration & dosage), Vaccines, Synthetic (genetics), Vaccines, Synthetic (immunology).
- MESH :
- chemical , administration & dosage : Antigens, Helminth, Helminth Proteins, Vaccines, Synthetic.
- chemical , blood : Antibodies, Helminth, Immunoglobulin G.
- chemical , genetics : Antigens, Helminth, Helminth Proteins, Recombinant Fusion Proteins, Thioredoxins, Vaccines, Synthetic.
- chemical , immunology : Antigens, Helminth, Recombinant Fusion Proteins, Thioredoxins, Vaccines, Synthetic.
- enzymology : Brugia malayi.
- genetics : Brugia malayi.
- immunology : Brugia malayi, Elephantiasis, Filarial, Leukocytes, Mononuclear.
- prevention & control : Elephantiasis, Filarial.
- chemical , secretion : Interferon-gamma, Interleukin-4, Interleukin-5.
- Animals, Cell Proliferation, Male, Mice, Mice, Inbred BALB C.
Abstract
Although multiple vaccine strategy for lymphatic filariasis has provided tremendous hope, the choice of antigens used in combination has determined its success in the previous studies. Multiple antigens comprising key vaccine candidates from different life cycle stages would provide a promising strategy if the antigenic combination is chosen by careful screening. In order to analyze one such combination, we have used a chimeric construct carrying the well studied B. malayi antigens thioredoxin (BmTRX) and venom allergen homologue (BmVAH) as a fusion protein (TV) and evaluated its immune responses in mice model. The efficacy of fusion protein vaccine was explored in comparison with the single antigen vaccines and their cocktail. In mice, TV induced significantly high antibody titer of 1,28,000 compared to cocktail vaccine TRX+VAH (50,000) and single antigen vaccine TRX (16,000) or VAH (50,000). Furthermore, TV elicited higher level of cellular proliferative response together with elevated levels of IFN-γ, IL-4 and IL-5 indicating a Th1/Th2 balanced response. The isotype antibody profile showed significantly high level of IgG1 and IgG2b confirming the balanced response elicited by TV. Immunization with TV antigen induced high levels of both humoral and cellular immune responses compared to either cocktail or antigen given alone. The result suggests that TV is highly immunogenic in mice and hence the combination needs to be evaluated for its prophylactic potential.
DOI: 10.2478/s11686-013-0160-8
PubMed: 24338307
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001781
- to stream PubMed, to step Curation: 001781
- to stream PubMed, to step Checkpoint: 001781
Links to Exploration step
pubmed:24338307Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.</title>
<author><name sortKey="Anugraha, Gandhirajan" sort="Anugraha, Gandhirajan" uniqKey="Anugraha G" first="Gandhirajan" last="Anugraha">Gandhirajan Anugraha</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Chennai, 600025, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Centre for Biotechnology, Anna University, Chennai, 600025</wicri:regionArea>
<wicri:noRegion>600025</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jeyaprita, Parasurama Jawaharlal" sort="Jeyaprita, Parasurama Jawaharlal" uniqKey="Jeyaprita P" first="Parasurama Jawaharlal" last="Jeyaprita">Parasurama Jawaharlal Jeyaprita</name>
</author>
<author><name sortKey="Madhumathi, Jayaprakasam" sort="Madhumathi, Jayaprakasam" uniqKey="Madhumathi J" first="Jayaprakasam" last="Madhumathi">Jayaprakasam Madhumathi</name>
</author>
<author><name sortKey="Sheeba, Tamilvanan" sort="Sheeba, Tamilvanan" uniqKey="Sheeba T" first="Tamilvanan" last="Sheeba">Tamilvanan Sheeba</name>
</author>
<author><name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24338307</idno>
<idno type="pmid">24338307</idno>
<idno type="doi">10.2478/s11686-013-0160-8</idno>
<idno type="wicri:Area/PubMed/Corpus">001781</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001781</idno>
<idno type="wicri:Area/PubMed/Curation">001781</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001781</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001781</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001781</idno>
<idno type="wicri:Area/Ncbi/Merge">006059</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.</title>
<author><name sortKey="Anugraha, Gandhirajan" sort="Anugraha, Gandhirajan" uniqKey="Anugraha G" first="Gandhirajan" last="Anugraha">Gandhirajan Anugraha</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Chennai, 600025, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Centre for Biotechnology, Anna University, Chennai, 600025</wicri:regionArea>
<wicri:noRegion>600025</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jeyaprita, Parasurama Jawaharlal" sort="Jeyaprita, Parasurama Jawaharlal" uniqKey="Jeyaprita P" first="Parasurama Jawaharlal" last="Jeyaprita">Parasurama Jawaharlal Jeyaprita</name>
</author>
<author><name sortKey="Madhumathi, Jayaprakasam" sort="Madhumathi, Jayaprakasam" uniqKey="Madhumathi J" first="Jayaprakasam" last="Madhumathi">Jayaprakasam Madhumathi</name>
</author>
<author><name sortKey="Sheeba, Tamilvanan" sort="Sheeba, Tamilvanan" uniqKey="Sheeba T" first="Tamilvanan" last="Sheeba">Tamilvanan Sheeba</name>
</author>
<author><name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name>
</author>
</analytic>
<series><title level="j">Acta parasitologica</title>
<idno type="eISSN">1896-1851</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies, Helminth (blood)</term>
<term>Antigens, Helminth (administration & dosage)</term>
<term>Antigens, Helminth (genetics)</term>
<term>Antigens, Helminth (immunology)</term>
<term>Brugia malayi (enzymology)</term>
<term>Brugia malayi (genetics)</term>
<term>Brugia malayi (immunology)</term>
<term>Cell Proliferation</term>
<term>Elephantiasis, Filarial (immunology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Helminth Proteins (administration & dosage)</term>
<term>Helminth Proteins (genetics)</term>
<term>Immunoglobulin G (blood)</term>
<term>Interferon-gamma (secretion)</term>
<term>Interleukin-4 (secretion)</term>
<term>Interleukin-5 (secretion)</term>
<term>Leukocytes, Mononuclear (immunology)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Recombinant Fusion Proteins (genetics)</term>
<term>Recombinant Fusion Proteins (immunology)</term>
<term>Thioredoxins (genetics)</term>
<term>Thioredoxins (immunology)</term>
<term>Vaccines, Synthetic (administration & dosage)</term>
<term>Vaccines, Synthetic (genetics)</term>
<term>Vaccines, Synthetic (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Agranulocytes (immunologie)</term>
<term>Animaux</term>
<term>Anticorps antihelminthe (sang)</term>
<term>Antigènes d'helminthe (administration et posologie)</term>
<term>Antigènes d'helminthe (génétique)</term>
<term>Antigènes d'helminthe (immunologie)</term>
<term>Brugia malayi (enzymologie)</term>
<term>Brugia malayi (génétique)</term>
<term>Brugia malayi (immunologie)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (immunologie)</term>
<term>Immunoglobuline G (sang)</term>
<term>Interféron gamma (sécrétion)</term>
<term>Interleukine-4 (sécrétion)</term>
<term>Interleukine-5 (sécrétion)</term>
<term>Mâle</term>
<term>Prolifération cellulaire</term>
<term>Protéines d'helminthes (administration et posologie)</term>
<term>Protéines d'helminthes (génétique)</term>
<term>Protéines de fusion recombinantes (génétique)</term>
<term>Protéines de fusion recombinantes (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Thiorédoxines (génétique)</term>
<term>Thiorédoxines (immunologie)</term>
<term>Vaccins synthétiques (administration et posologie)</term>
<term>Vaccins synthétiques (génétique)</term>
<term>Vaccins synthétiques (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antigens, Helminth</term>
<term>Helminth Proteins</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term>
<term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Helminth</term>
<term>Helminth Proteins</term>
<term>Recombinant Fusion Proteins</term>
<term>Thioredoxins</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Helminth</term>
<term>Recombinant Fusion Proteins</term>
<term>Thioredoxins</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antigènes d'helminthe</term>
<term>Protéines d'helminthes</term>
<term>Vaccins synthétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Brugia malayi</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Brugia malayi</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Brugia malayi</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes d'helminthe</term>
<term>Brugia malayi</term>
<term>Protéines d'helminthes</term>
<term>Protéines de fusion recombinantes</term>
<term>Thiorédoxines</term>
<term>Vaccins synthétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Agranulocytes</term>
<term>Antigènes d'helminthe</term>
<term>Brugia malayi</term>
<term>Filariose lymphatique</term>
<term>Protéines de fusion recombinantes</term>
<term>Thiorédoxines</term>
<term>Vaccins synthétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Brugia malayi</term>
<term>Elephantiasis, Filarial</term>
<term>Leukocytes, Mononuclear</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term>
<term>Immunoglobuline G</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="secretion" xml:lang="en"><term>Interferon-gamma</term>
<term>Interleukin-4</term>
<term>Interleukin-5</term>
</keywords>
<keywords scheme="MESH" qualifier="sécrétion" xml:lang="fr"><term>Interféron gamma</term>
<term>Interleukine-4</term>
<term>Interleukine-5</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Proliferation</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Filariose lymphatique</term>
<term>Mâle</term>
<term>Prolifération cellulaire</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Although multiple vaccine strategy for lymphatic filariasis has provided tremendous hope, the choice of antigens used in combination has determined its success in the previous studies. Multiple antigens comprising key vaccine candidates from different life cycle stages would provide a promising strategy if the antigenic combination is chosen by careful screening. In order to analyze one such combination, we have used a chimeric construct carrying the well studied B. malayi antigens thioredoxin (BmTRX) and venom allergen homologue (BmVAH) as a fusion protein (TV) and evaluated its immune responses in mice model. The efficacy of fusion protein vaccine was explored in comparison with the single antigen vaccines and their cocktail. In mice, TV induced significantly high antibody titer of 1,28,000 compared to cocktail vaccine TRX+VAH (50,000) and single antigen vaccine TRX (16,000) or VAH (50,000). Furthermore, TV elicited higher level of cellular proliferative response together with elevated levels of IFN-γ, IL-4 and IL-5 indicating a Th1/Th2 balanced response. The isotype antibody profile showed significantly high level of IgG1 and IgG2b confirming the balanced response elicited by TV. Immunization with TV antigen induced high levels of both humoral and cellular immune responses compared to either cocktail or antigen given alone. The result suggests that TV is highly immunogenic in mice and hence the combination needs to be evaluated for its prophylactic potential.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24338307</PMID>
<DateCreated><Year>2013</Year>
<Month>12</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>07</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1896-1851</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>58</Volume>
<Issue>4</Issue>
<PubDate><Year>2013</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Acta parasitologica</Title>
<ISOAbbreviation>Acta Parasitol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.</ArticleTitle>
<Pagination><MedlinePgn>468-77</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2478/s11686-013-0160-8</ELocationID>
<Abstract><AbstractText>Although multiple vaccine strategy for lymphatic filariasis has provided tremendous hope, the choice of antigens used in combination has determined its success in the previous studies. Multiple antigens comprising key vaccine candidates from different life cycle stages would provide a promising strategy if the antigenic combination is chosen by careful screening. In order to analyze one such combination, we have used a chimeric construct carrying the well studied B. malayi antigens thioredoxin (BmTRX) and venom allergen homologue (BmVAH) as a fusion protein (TV) and evaluated its immune responses in mice model. The efficacy of fusion protein vaccine was explored in comparison with the single antigen vaccines and their cocktail. In mice, TV induced significantly high antibody titer of 1,28,000 compared to cocktail vaccine TRX+VAH (50,000) and single antigen vaccine TRX (16,000) or VAH (50,000). Furthermore, TV elicited higher level of cellular proliferative response together with elevated levels of IFN-γ, IL-4 and IL-5 indicating a Th1/Th2 balanced response. The isotype antibody profile showed significantly high level of IgG1 and IgG2b confirming the balanced response elicited by TV. Immunization with TV antigen induced high levels of both humoral and cellular immune responses compared to either cocktail or antigen given alone. The result suggests that TV is highly immunogenic in mice and hence the combination needs to be evaluated for its prophylactic potential.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anugraha</LastName>
<ForeName>Gandhirajan</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Centre for Biotechnology, Anna University, Chennai, 600025, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jeyaprita</LastName>
<ForeName>Parasurama Jawaharlal</ForeName>
<Initials>PJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Madhumathi</LastName>
<ForeName>Jayaprakasam</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sheeba</LastName>
<ForeName>Tamilvanan</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kaliraj</LastName>
<ForeName>Perumal</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>12</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Poland</Country>
<MedlineTA>Acta Parasitol</MedlineTA>
<NlmUniqueID>9301947</NlmUniqueID>
<ISSNLinking>1230-2821</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015801">Helminth Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015848">Interleukin-5</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C446035">venom allergen antigen-like protein 1, Brugia malayi</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>207137-56-2</RegistryNumber>
<NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>52500-60-4</RegistryNumber>
<NameOfSubstance UI="D013879">Thioredoxins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017178" MajorTopicYN="N">Brugia malayi</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015801" MajorTopicYN="N">Helminth Proteins</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
<QualifierName UI="Q000557" MajorTopicYN="N">secretion</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015847" MajorTopicYN="N">Interleukin-4</DescriptorName>
<QualifierName UI="Q000557" MajorTopicYN="N">secretion</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015848" MajorTopicYN="N">Interleukin-5</DescriptorName>
<QualifierName UI="Q000557" MajorTopicYN="N">secretion</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013879" MajorTopicYN="N">Thioredoxins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>07</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>12</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24338307</ArticleId>
<ArticleId IdType="doi">10.2478/s11686-013-0160-8</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Inde</li>
</country>
</list>
<tree><noCountry><name sortKey="Jeyaprita, Parasurama Jawaharlal" sort="Jeyaprita, Parasurama Jawaharlal" uniqKey="Jeyaprita P" first="Parasurama Jawaharlal" last="Jeyaprita">Parasurama Jawaharlal Jeyaprita</name>
<name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name>
<name sortKey="Madhumathi, Jayaprakasam" sort="Madhumathi, Jayaprakasam" uniqKey="Madhumathi J" first="Jayaprakasam" last="Madhumathi">Jayaprakasam Madhumathi</name>
<name sortKey="Sheeba, Tamilvanan" sort="Sheeba, Tamilvanan" uniqKey="Sheeba T" first="Tamilvanan" last="Sheeba">Tamilvanan Sheeba</name>
</noCountry>
<country name="Inde"><noRegion><name sortKey="Anugraha, Gandhirajan" sort="Anugraha, Gandhirajan" uniqKey="Anugraha G" first="Gandhirajan" last="Anugraha">Gandhirajan Anugraha</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006059 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 006059 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:24338307 |texte= Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:24338307" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |